Creo Medical Group PLC (LON:CREO) Insider Christopher Paul Hancock Acquires 4,712 Shares

Creo Medical Group PLC (LON:CREO) insider Christopher Paul Hancock purchased 4,712 shares of the business’s stock in a transaction dated Monday, January 20th. The stock was bought at an average cost of GBX 19 ($0.23) per share, for a total transaction of £895.28 ($1,103.78).

Creo Medical Group Price Performance

Shares of LON CREO opened at GBX 18.50 ($0.23) on Wednesday. Creo Medical Group PLC has a 52-week low of GBX 12 ($0.15) and a 52-week high of GBX 43 ($0.53). The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24. The stock has a market cap of £66.93 million, a P/E ratio of -308.33 and a beta of 0.86. The firm has a 50 day moving average price of GBX 17.55 and a 200 day moving average price of GBX 23.50.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.